Cargando…

BCOR involvement in cancer

BCOR is a gene that encodes for an epigenetic regulator involved in the specification of cell differentiation and body structure development and takes part in the noncanonical polycomb repressive complex 1. This review provides a comprehensive summary of BCOR’s involvement in oncology, illustrating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Astolfi, Annalisa, Fiore, Michele, Melchionda, Fraia, Indio, Valentina, Bertuccio, Salvatore N, Pession, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595546/ https://www.ncbi.nlm.nih.gov/pubmed/31150281 http://dx.doi.org/10.2217/epi-2018-0195

Ejemplares similares

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase
por: Bertuccio, Salvatore Nicola, et al.
Publicado: (2017)

Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature
por: Serravalle, Salvatore, et al.
Publicado: (2016)

Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney
por: Astolfi, Annalisa, et al.
Publicado: (2015)

Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)
por: Fiore, Michele, et al.
Publicado: (2023)

iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death
por: Messelodi, Daria, et al.
Publicado: (2021)

Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
por: Pession, Andrea, et al.
Publicado: (2008)

Negative pressure treatment for necrotizing fasciitis after chemotherapy
por: Melchionda, Fraia, et al.
Publicado: (2011)

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML
por: Lonetti, Annalisa, et al.
Publicado: (2020)

Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing
por: Masetti, Riccardo, et al.
Publicado: (2016)

Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation
por: Messelodi, Daria, et al.
Publicado: (2023)

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene
por: Masetti, Riccardo, et al.
Publicado: (2017)

Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10
por: Bacci, Lorenza, et al.
Publicado: (2022)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
por: Pisapia, David J., et al.
Publicado: (2020)

Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias
por: Anselmi, Laura, et al.
Publicado: (2020)

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
por: Astolfi, Annalisa, et al.
Publicado: (2013)

CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity
por: Masetti, Riccardo, et al.
Publicado: (2018)

The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model
por: Bertuccio, Salvatore Nicola, et al.
Publicado: (2019)

The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor
por: Astolfi, Annalisa, et al.
Publicado: (2020)

Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies
por: Tanaka, Tomoyuki, et al.
Publicado: (2017)

Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML
por: Bertuccio, Salvatore Nicola, et al.
Publicado: (2021)

Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR ‐rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022)

Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
por: Togni, Marco, et al.
Publicado: (2015)

DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
por: Masetti, Riccardo, et al.
Publicado: (2013)

Targeted therapy in SDH-deficient GIST
por: Nannini, Margherita, et al.
Publicado: (2021)

Spleen nodules: a potential hallmark of Visceral Leishmaniasis in young children
por: Melchionda, Fraia, et al.
Publicado: (2014)

Filaggrin Loss-of-Function Mutations Are Risk Factors for Severe Food Allergy in Children with Atopic Dermatitis
por: Astolfi, Annalisa, et al.
Publicado: (2021)

ETMR-03. Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022)

Paediatric BCOR ‐associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 15
por: Goh, Jian Yuan, et al.
Publicado: (2022)

BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2007)

Role of CBL Mutations in Cancer and Non-Malignant Phenotype
por: Leardini, Davide, et al.
Publicado: (2022)

Molecular Identification and In Silico Protein Analysis of a Novel BCOR-CLGN Gene Fusion in Intrathoracic BCOR-Rearranged Sarcoma
por: Chang Chien, Yi-Che, et al.
Publicado: (2023)

Correction: BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2008)

The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation
por: Indio, Valentina, et al.
Publicado: (2020)

ETMR-11. Transcriptional changes upon knockdown of alteredBCOR/BCORL1 transcripts in preclinical models of CNS embryonal tumors with BCOR-related alterations
por: Piontek, Martin, et al.
Publicado: (2022)

Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
por: Kelly, Madison J., et al.
Publicado: (2019)

Specific and Sensitive Diagnosis of BCOR-ITD in Various Cancers by Digital PCR
por: Barets, Doriane, et al.
Publicado: (2021)

Rare Case of BCOR::CCNB3 Sarcoma of Bone
por: Arai, Yumi, et al.
Publicado: (2023)

Oculofaciocardiodental syndrome caused by a novel BCOR variant
por: Yamashita, Tomoyo, et al.
Publicado: (2023)

The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_55gc8kpquhf274ntamja1ptob0